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Abstract
Necrotizing fasciitis is a severe soft tissue infection characterized by rapidly progressing necrosis,
involving subcutaneous tissues. This rare condition carries high mortality rate and require prompt
diagnosis and urgent treatment with radical debridement and antibiotics.
We describe a case of 21-year old man who presented with the history of trivial injury to the knee.
Initially he was admitted and treated for septic arthritis but later was diagnosed as necrotizing
fasciitis which was successfully treated with no ill effects what so ever from this devastating
condition.
This rare condition has been reported in literature but still early diagnosis, which is a key for
successful treatment, remains a challenge.
Background
Necrotizing fasciitis(NF) is a severe soft tissue infection
characterized by rapidly progressing necrosis involving
mainly the fascia and subcutaneous tissues, but can also
extend to involve muscles and skin. This rare, life-threat-
ening condition has been recognized since 18th century
with various names including phagedena gangrenosum,
hospital gangrene, Meleney's gangrene, Fournier's gan-
grene etc. Although rare, it is frequent enough that sur-
geons will likely have to be involved with the
management of at least 1 patient with NF during their
practice, but it is infrequent enough to achieve complete
familiarity with the disease. Establishing the diagnosis of
NF can be challenging in treating these patients, and
knowledge of all available tools is key for early and accu-
rate diagnosis. The purpose of this article is to review the
different tools available for diagnosis and the treatment
principles for NF.
Case
A 21-year old man with no co-morbidities was referred to
the regional orthopedic unit from emergency department
of another hospital in the vicinity, with the history of triv-
ial injury to his right knee two days ago. He accidentally
hit his right knee to the wall two days back and sustained
an abrasion to his knee. He started complaining of pain in
his knee the next day and had to stop working. Pain got
worse over night and he attended the emergency depart-
ment the next day, from where he was referred to us with
the suspicion of septic arthritis or cellulitis. He received
intra-venous benzyl-penicillin and flucloxacillin in the
emergency department.
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On arrival, he was afebrile and systemically stable but in
considerable pain. Examination of the right knee revealed
small superficial wound over patella, slight redness and
increased temperature in surrounding area with grade I
effusion in the joint. Movements of the joint was reduced
and associated with severe pain. Neurological and vascu-
lar examination of the limb was satisfactory.
The initial blood investigation revealed white cell count
(WCC) count of 18.6 × 109/L, C-reactive protein (CRP) of
63.1 mg/L, and hemoglobin (Hb) level of 15 g/dL. X ray
of the right knee did not show any bony injury or gas in
the soft tissues. A working diagnosis of septic arthritis sec-
ondary to traumatic wound was made and urgent arthro-
scopic washout of the knee was performed that night.
Arthroscopy revealed inflamed synovium and only 10 cc
of fluid was drained from the knee. Urgent microscopy
and gram stain of the fluid and later culture failed to
reveal any organism.
Post-operatively, intravenous flucloxacillin and benzyl
penicillin was continued along with gentamycin. Even
after 72 hours of antibiotics patient remained sympto-
matic. Although he remained afebrile at all times, his pain
and tenderness continued to increase in distal thigh and
blood investigations revealed a marked increase in
inflammatory markers (CRP of 181 and ESR of 37). Con-
sidering the failure to respond with intravenous antibiot-
ics, negative arthroscopy and increasing tenderness in
distal thigh, a suspicion of necrotizing fasciitis was made.
Urgent contrast enhanced Computed Tomogram (CT)
scan (Fig 1) of his right thigh and knee was performed that
revealed marked inflammatory stranding and low attenu-
ation with suspicion of necrosis mainly in rectus femoris
and vastus lateralis. Patient was taken to theatre urgently
and fasciotomy performed through antero-lateral
approach of the thigh which confirmed the CT findings of
necrotic fascia and muscles (Fig 2 and 3). Thorough deb-
ridement of rectus femoris and vastus lateralis was per-
formed, wound was washed thoroughly and packed with
betadine soaked swabs.
The case was discussed with microbiologist and intra-
venous (IV) clindamycin and ciprofloxacin was added
along with flucloxacillin and benzyl penicillin. IV hydra-
tion and oxygen therapy was maintained through out,
with close observation of renal functions which remained
stable.
Patient was taken to theatre again in 48 hours for re exam-
ination which showed more necrotic area in rectus muscle
which was debrided again. Further two washouts with 48
hours interval, did not show any progression of necrosis
and wound was closed gradually with staples and shoe
lace technique. IV antibiotics were continued for 14 days
followed by oral clindamycin and ciprofloxacin for 5
weeks. He remained stable systemically and responded
well to the treatment as evidenced by normalizing inflam-
matory markers. The diagnosis was confirmed on tissue
histology but causative organism remained unidentified.
CT scan of right thigh, showing inflammatory stranding and  low attenuation in vastus latralis (arrow) Figure 1
CT scan of right thigh, showing inflammatory strand-
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Patient made an amazing recovery from this limb and life
threatening condition which was made possible by multi-
disciplinary approach involving orthopedics, general sur-
gery, radiology, microbiology, physiotherapy and dieti-
cians. Patient was discharged home after 19 days of in-
hospital stay. At final follow up 3 months later he had full
range of motion in his right knee and grade 4 power in
knee extensors.
Disscussion
Necrotizing fasciitis is a rare, potentially fatal bacterial
infection characterized by widespread necrosis of the sub-
cutaneous tissue, superficial fascia and skin. This rare, life-
threatening condition has been recognized since 18th cen-
tury with various names including phagedena gangreno-
sum, hospital gangrene, Meleney's gangrene, Fournier's
gangrene etc. A Confederate Army Surgeon, Joseph Jones,
wrote one of the earliest descriptions of necrotizing soft
tissue infections in soldiers during the American civil war
in 1871 and reported a mortality rate of 46% [1]. In 1883,
the French physician, Jean Alfred Fournier, described a
similar NSTI of the perineum in five male patients – a
process that continues to bear his name. In 1952 the con-
dition was described as necrotizing fasciitis by Wilson for
the first time to include both gas-forming and non-gas-
forming necrotizing infection and stated that fascial
necrosis is the sine qua non of this process. [2]. More
recently, the term necrotizing soft tissue infection (NSTI)
has been suggested to encompass all of these necrotizing
infections and advocate an approach to all of them that
uses the same principles for diagnostic and treatment
strategies. This will allow for earlier diagnosis and expe-
dited treatment, which are essential for improving out-
comes and decreasing mortality in patients with NSTI [3].
Incidence and classification
The incidence has been reported approximately 1,000
cases per year in the United States or 0.4 to 0.53 cases per
100,000[4,5]. Not only individuals with pre-existing co-
morbidities are affected but also young and healthy indi-
viduals can be affected. NSTI can be classified according to
the anatomic location involved or the depth of infection
as necrotizing adiposities, fasciitis, or myositis. Most com-
monly NSTI is classified on the basis of microbiology as
type I, being polymicrobial, type II, being monomicrobial
and type III, being caused by marine vibrio species. These
classification systems are not clinically significant as they
do not change the management of the patient. This condi-
tion can involve any part of body but primarily involves
extremities, abdomen or perineum. Anaya et al in their
study of 150 established cases of necrotizing fasciitis esti-
mated that extremities were the most common site of
infection in 57.8% followed by the abdomen and peri-
neum [6].
Microbiology
There are two main groups of necrotizing fasciitis depend-
ing on microbiology. Type-I NF are polymicrobial.
Approximately 55% to 75% of all cases result from type I
infection and most common bacterial species include
Gram-positive cocci (streptococci, staphylococcal spe-
cies), enterococci and gram-negative enterobacteriaceae
(Escherichia coli, Acinetobecter species, Pseudomonas
species and Klebsiella species). Bacteroides species are the
most common anaerobes, while Clostridial species are an
infrequent isolate [7-11]. Type I infections are often diag-
nosed in immunocompromised patients and tend to
Intra-operative picture of surgical debridement of thigh  through antero-lateral approach Figure 2
Intra-operative picture of surgical debridement of 
thigh through antero-lateral approach.
Intra-operative picture showing necrotic fascia and subcuta- neous tissue as evident by lack of bleeding (arrow) Figure 3
Intra-operative picture showing necrotic fascia and 
subcutaneous tissue as evident by lack of bleeding 
(arrow).Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2009, 17:28 http://www.sjtrem.com/content/17/1/28
Page 4 of 7
(page number not for citation purposes)
occur in the perineal and trunk areas [12]. Type-II infec-
tions are monomicrobial and usually caused by group A
Streptococcus (Streptococcus pyogenes) either alone or in
association with Staphylococcus aureus. Streptococal
infection can be associated with toxic shock syndrome.
Recently there has been an increasing incidence of com-
munity-acquired methicillin-resistant Staphylococcus
aureus (MRSA) soft-tissue infection, particularly in IV
drug abusers [13-15]. Some other organisms has been
reported as a rare cause of type-II infection like Klebsiella
species [16] and group-B streptococcus [17]. Type II NF is
far less common than type I infection and tends to occur
in otherwise healthy, young, immunocompetent hosts
and is classically located on the extremities. There is
another subtype due to marine Vibrio species (e.g. V. vul-
nificus) [18] associated with marine injuries and contact
with raw sea food. Although this is the least common
type, it is associated with a fulminant course and can lead
to multisystem organ failure within 24 hours of infection.
Wong et al [10] in their study of 89 patients with necrotiz-
ing fasciitis described the causative micro organisms as
obtained from first debridement sample. According to
their study a single organism was identified in twenty-five
patients (28.1%), multiple organisms were identified in
forty-eight patients (53.9%), and no organism was identi-
fied in sixteen patients (18.0%). Streptococcal species,
identified in thirty-one patients, were the most common
isolates. Forty-eight (66%) of the positive cultures were
polymicrobial necrotizing infections (Type-I NF).
Pathophysiology
Necrotizing fasciitis is characterized by rapidly spreading
infection in the subcutaneous tissues. Microbial invasion
of the subcutaneous (SC) tissues occurs either through
external trauma or direct spread from a perforated viscus
(particularly colon, rectum, or anus). Bacteria then track
SC, producing endo and exotoxins [19] that cause micro-
vascular thrombosis[20], tissue ischemia, liquefactive
necrosis, and often systemic illness [21] which can
progress to septic shock, multisystem organ dysfunction,
and death. Tissue ischemia, impedes oxidative destruction
of bacteria by polymorphonuclear cells and prevents ade-
quate delivery of antibiotics. Hence, surgical debridement
is the mainstay therapy for NSTI, and antibiotic therapy
alone is of little value and only mask the severity of the
symptoms [22].
Risk factors
The commonest predisposing factor for NF of extremity is
a history of drug abuse and multiple needle punctures in
the affected site, this was found in 129 (33%) patients in
a systematic review of NF of upper and lower limb[23].
Other predisposing factors include trauma, fish-fin injury,
chronic skin ulcer, burns, post operative wound infection,
insect bite and colo-cutaneous fistula [24-27].
Diabetes Mellitus(DM) is the leading predisposing under-
lying medical condition because of peripheral neuropa-
thy, peripheral vascular disease and immuno-
suppression. According to Elliot et al [7] presence of DM
does not affect mortality unless it occur with certain other
diseases. Other associated diseases include immuno-defi-
ciency, alcoholism, chronic renal failure, liver cirrhosis,
HIV, malignancy, steroids and peripheral vascular disease
[28-30].
Clinical manifestations
Lack of cutaneous findings early in the disease make the
diagnosis challenging and high index of suspicion is
essential. Common sign and symptoms of the disease are
summarized in [Table 1]. The most common early signs
are erythema, local warmth, skin induration, and edema.
These signs often make early diagnosis difficult and the
condition is often diagnosed as cellulites, abscess or septic
arthritis as in our case and the diagnosis of necrotizing fas-
ciitis is only suspected when patient fail to respond to
broad spectrum intravenous antibiotics or develop cuta-
neous manifestations. Pain out of proportion to the
apparent severity of the lesion should alert the physician
to the possible diagnosis of Necrotizing fasciitis. Patches
of skin necrosis, tissue crepitus, fluctuance and systemic
evidence of sepsis such as hyperthermia, tachycardia and
hypotension are alarming signs.
Diagnostic tools
Early diagnosis of NF is not always possible due to paucity
of cutaneous findings early in the disease therefore high
index of suspicion is important in infected cases that are
refractory to antibiotics. There are a wide variety of diag-
nostic tools that can be used as an adjunct for diagnosis.
Wong et al. [31] created a score (laboratory risk indicator
for necrotizing fasciitis score) to discriminate between
NSTI and non-necrotizing soft-tissue infection. They iden-
tified 6 independent variables associated with NSTI. Each
variable, if present, gives a specific number of points
toward the final score [Table 2]. The total score had a
Table 1: Clinical manifestations of Necrotizing Fasciitis
Erythema
Pain
Warmth
Edema
Induration
Fluctuance
Crepitus
Skin necrosis
Bullae
Abscess
Fever
HypotentionScandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2009, 17:28 http://www.sjtrem.com/content/17/1/28
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range of 0–13, and Wong and colleagues showed that, for
intermediate and high-risk patients (score, > 6) had a PPV
of 92% and a NPV of 96% [31].
Other diagnostic adjuncts like ultrasound, CT scan and
magnetic resonance imaging (MRI) are helpful in suspi-
cious cases. The usefulness of MRI in the diagnosis of NF
has been supported in a study by Rahmouni et al. [32],
who in 36 patients were able to differentiate between non-
necrotizing cellulites that would respond to medical treat-
ment and severe necrotizing infection that require rapid,
life-saving surgery. Wang and Hung [33] investigated the
use of tissue oxygen monitoring with near-infrared spec-
troscopy for the diagnosis of NF. They reported that tissue
oxygen saturation less than 70% had a sensitivity of 100%
and a specificity of 97%. The authors of this study propose
that this method may offer a reliable non-invasive
approach of assessing lower extremities at risk of necrotis-
ing fasciitis. Examination of a frozen section biopsy spec-
imen from the compromised site that includes deep fascia
and possibly muscle has been suggested as well, as a
means to achieve earlier diagnosis of NSTI in patients
[20,34].
Treatment
Early diagnosis and prompt treatment including surgical
debridement and braod spectrum antibiotics is the key to
successful treatment in necrotizing fasciitis [35,36]. The
initial regimen should include agents effective against aer-
obic gram-positive cocci, gram-negative rods, and a vari-
ety of anaerobes [37]. The usual multidrug regimens
include high-dose penicillin, high-dose clindamycin, and
a fluoroquinolone or an aminoglycoside for coverage of
gram-negative organisms. Vancomycin, or linezolid
should be considered until MRSA infection has been
excluded [3]. This should be accompanied with support-
ive measures such as fluid replacement, blood pressure
support, analgesia, nutritional support and intensive care
involvement etc. Intravenous immunoglobulins (IVIg)
[38,39] and Hyberbaric oxygen (HBO) therapy has also
been suggested as an adjunct to other treatments. There is
no agreement as to the usefulness of HBO for NF [40,41].
When NF is established or highly suspected, urgent explo-
ration and debridement of tissue is the cornerstone of suc-
cessful management [37]. Surgical exploration also aid in
the diagnosis of NF. The operative findings of grayish
necrotic deep fascia, a lack of resistance to blunt dissec-
tion, lack of bleeding of the fascia, and presence of foul-
smelling "dishwater" pus confirms the diagnosis. Tissue
samples should be sent for gram staining, culture and his-
tology. C H Wong [42], described his approach to debri-
dement in NF which consists of 4 steps: (1) confirming
the diagnosis (2) defining the extent of fasciitis; (3) surgi-
cal excision; and (4) post-excision wound care. The extent
of the infection is defined by probing the wound bluntly,
followed by systematic excision. He classified the infected
skin into zones 1, 2, and 3. Zone 1 is necrotic tissue. Zone
2 is infected but potentially salvageable soft tissue, and
zone 3 is non-infected skin. Zone 1 is completely excised.
Zone 2 is meticulously assessed and cut back as necessary
to remove nonviable tissue while maximally preserving
salvageable tissue. Zone 3 is left alone.
The aim of surgical debridement is to remove all infected
tissue in a single operation. This halts the progression of
the fasciitis and minimizes unnecessary returns to the
operating room. In most of the cases repeat debridement
in needed before wound closure.
Wound closure should be carefully planned as early clo-
sure carries the risk of residual infection and poor wound
healing. The wound must demonstrate that the healing
phase has started before any attempt to closure. Several
methods has been used for wound closure such as second-
ary suturing, shoe lace technique, skin grafting, muscle
Table 2: Laboratory Risk Indicator for Necrotizing Fasciitis 
Score [31].
Variable Score
C-reactive protein
< 150 0
≥ 150 4
WBC(cells/mm3)
< 15 0
15–25 1
> 25 2
Hemoglobin(g/dL)
> 13.5 0
11–13.5 1
< 11 2
Sodium(mmol/L)
≥ 135 0
< 135 2
Creatinine(mcg/L)
≤ 141 0
> 141 2
Glucose(mmol/L)
≤ 10 0
> 1 1Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2009, 17:28 http://www.sjtrem.com/content/17/1/28
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flaps etc. Vacuum-assisted closure (VAC) [24] technique
has found an extended use in the field of open wound
management and has shown decreased morbidity associ-
ated with wound care.
Mortality
The mortality associated with the disease is high and has
been reported from 6% to as high as 76% [43-51] [Table
3]. McHenry et al [9] in their study reviewed the determi-
nants of mortality in patients with necrotizing soft tissue
infections. They summarized the reported mortality rates
from different studies. The cumulative mortality rate was
34% (6% to 76%) and 29% in their series of patients. The
average time from admission to operation was 90 hours in
non-survivors versus 25 hours in survivors. They con-
cluded that early debridement was associated with a sig-
nificant decrease in mortality. Similar findings were also
reported by Wong et al [10]. In a retrospective review of 89
consecutive patients with necrotizing fasciitis, they con-
cluded that the most common associated co-morbidity
was diabetes mellitus (sixty-three patients; 70.8%).
Advanced age, two or more associated co-morbidities, and
a delay in surgery of more than twenty-four hours
adversely affected the outcome. Multivariate analysis
showed that only a delay in surgery of more than twenty-
four hours was correlated with increased mortality [10].
Conclusion
NF is a rare life threatening condition that requires
prompt recognition and aggressive surgical debridement
along with broad spectrum antibiotics. Early diagnosis of
the condition poses a challenge and high index of suspi-
cion in crucial. Surgical debridement must be aggressive
and complete and new therapeutic modalities like HBO
and VAC may be considered for wound management.
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